Lorazepam as an adjuvant to haloperidol for agitated delirium at the end of life: A double-blind randomized controlled trial Meeting Abstract
| Authors: | Hui, D.; Frisbee-Hume, S.; Wilson, A.; Dibaj, S.; Nguyen, T.; De La Cruz, M. G. J.; Walker, P.; Delgado-Guay, M.; Vidal, M.; Zhukovsky, D. S.; Epner, D. E.; Reddy, A. S.; Tanco, K.; Williams, J. L.; Hall, S.; Liu, D. D.; Hess, K. R.; Amin, S. R.; Breitbart, W.; Bruera, E. |
| Abstract Title: | Lorazepam as an adjuvant to haloperidol for agitated delirium at the end of life: A double-blind randomized controlled trial |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 501s |
| Language: | English |
| ACCESSION: | WOS:000411932204129 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.10003 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10003 -- Source: Wos |
